Mergers & Acquisitions

MSD has continued to strengthen its leadership in the home infusion space while also significantly expanding its presence across the broader post-acute landscape.

Spokesperson says the details are still being worked out about physical locations or shared access to care services and they hope to finalize the arrangement this year.

The move comes during a prolonged period of financial struggle for CHS, which has seen diminished cash flow and admissions, and a big hit from bad debt.

Key stakeholders had a hearing in front of the Public Health Council earlier this month where councilors voted unanimously to approve the deal.

Companies say the cross-sector partnership will create open source platform that it hopes other tech companies will use to innovate.

Bipartisan bill is expected after questions are answered by April 26 deadline; Senate HELP committee gets ready to markup Opioid Crisis Response Act.

The deal was first announced last month. Financial terms were not disclosed.

Biopharmaceuticals garnered about half of the funding so far this year.

A look at the latest facilities building and modernization projects just getting underway.

What makes an investment bank and a conglomerate real estate company interested in the healthcare space, and what do they have to offer there? JPMorgan Chase CEO Jamie Dimon shed some light on that question, not to mention the question of what exactly this venture will do, in a letter to shareholders published last week as part of the bank's annual report.